HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

515.560

-16.828-3.16%

Number of Gainers:6

Number of Losers:26

Number of Flat:1

PE:- -

High:526.804

Open:526.804

Low:504.120

Close:532.388

Volume:37.26M

Turnover:983.79M

Market Cap:325.98B

Float Cap:291.58B

Loading ...

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25

Model Companies Enter Biopharma: 2026 Becomes Pivotal Year for AI Drug Discovery

UBS Keeps "Buy" Rating on InnoCare Pharma with HK$21.80 Target Price

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

ALPHAMAB-B (09966) Spends HK$290,300 to Repurchase 35,000 Shares on September 25

EDDING GENOR (06998) Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25

Peijia Medical Says B. Braun's Intracranial Drug-Coated Balloon Gets China Approval

MT Newswires Live

ANTENGENE-B (06996) Spends HK$504,900 to Repurchase 147,000 Shares on September 25

UBS Positive on InnoCare Pharma's Collaboration with Eli Lilly on Novel Target Programs

Peijia Medical-B (09996): Shenpuchang™ SeQuent® Please CIS Paclitaxel Drug-Coated Intracranial Balloon Dilatation Catheter Registration Application Approved by National Medical Products Administration

Peijia Medical - Shanghai Achieva Medical Suzhou Obtains Exclusive Distribution Rights for Sequent® Please CIS in Chinese Mainland

THOMSON REUTERS

Peijia Medical - Sequent® Please CIS Balloon Dilatation Catheter Receives Nmpa Registration Approval

THOMSON REUTERS

Hong Kong Stock Market Movers: CRO Sector Leads Gains as Citi Signals Positive Outlook for U.S. Licensing Policy Toward Chinese Drugmakers, Remains Bullish on Innovative Drugs and Biotech

Kobayashi Pharmaceutical Says It Has Received Preliminary Take-Private Offer

Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention

CStone Pharma CEO Buys HK$2.7 Million of Shares

MT Newswires Live

Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices

Dizal Pharmaceutical Executives Including CFO Lu Hongbin Plan to Reduce Shareholdings

CStone Pharma-B (02616) Announces CEO and Executive Director Yang Jianxin's Purchase of 496,000 Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK1574/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":515.5602,"timestamp":1790928487328,"preClose":532.3884,"halted":0,"volume":37258611,"delay":0,"changeRate":-0.031609,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-16.828247,"latestTime":"10-02 16:00:00","open":526.80365,"high":526.80365,"low":504.12042,"amount":983786061.5,"amplitude":0.042607,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":3.967371,"peRate":176.437057,"turnoverRate":0.001378,"increases":5,"decrements":27,"flats":0,"marketCap":325975381968,"floatMarketCap":291576058040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":526.80365,"amplitude":0.042607,"preClose":532.3884,"low":504.12042,"pbRate":"3.967371","latestPrice":515.5602,"volume":37258611,"delay":0,"open":526.80365,"prevYearClose":556.26263,"prevWeekClose":495.27,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":495.278,"twentyDayClose":515.473,"sixtyDayClose":490.453,"secType":"PLATE","market":"HK","turnoverRate":0.001378,"peRate":176.437057,"marketCap":325975381968,"floatMarketCap":291576058040,"timestamp":1790928487328,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196699729","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1196699729","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196699729?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:50","pubTimestamp":1790556615,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has released an announcement stating that on September 25, 2026, the company spent HK$1.1571 million to repurchase 54,000 shares.The announcement disclosed the share buyback details, with the company allocating HK$1.1571 million for the repurchase of 54,000 shares on that date.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1100","02190","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121417907","title":"EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1121417907","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121417907?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:40","pubTimestamp":1790556031,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has issued an announcement stating that on September 25, 2026, the company spent HK$6.8 million to repurchase 4 million shares, with a repurchase price of HK$1.695 to HK$1.7 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192832662","title":"Model Companies Enter Biopharma: 2026 Becomes Pivotal Year for AI Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1192832662","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192832662?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:21","pubTimestamp":1790554886,"startTime":"0","endTime":"0","summary":"On September 23, U.S. artificial intelligence startup Anthropic announced that its Claude model helped discover a new enzyme system, marking the first achievement of its biology research program.Just...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VTHR","BK4585","AIPO","CHAT","ARTY","01477","161726","QTOC","399441","BK1191","XBI","AGIX","BK1574","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191016793","title":"UBS Keeps \"Buy\" Rating on InnoCare Pharma with HK$21.80 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1191016793","media":"Deep News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191016793?lang=en_us&edition=fundamental","pubTime":"2026-09-27 12:30","pubTimestamp":1790483430,"startTime":"0","endTime":"0","summary":"UBS has released a research report maintaining its \"Buy\" rating and HK$21.80 target price for InnoCare Pharma (09969).InnoCare Pharma has entered into a collaboration with Eli Lilly (LLY.US) to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688428","BK1574","09969","EWH","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187010326","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1187010326","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187010326?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:52","pubTimestamp":1790347940,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 25, 2026, it spent HK$1.1571 million to repurchase 54,000 shares.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1100","BK1574","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179986129","title":"ALPHAMAB-B (09966) Spends HK$290,300 to Repurchase 35,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1179986129","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179986129?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:00","pubTimestamp":1790341217,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that the company spent HK$290,300 to repurchase 35,000 shares on September 25, 2026, at a repurchase price of HK$8.2 to HK$8.34 per share.For more major Hong Kong stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178594983","title":"EDDING GENOR (06998) Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1178594983","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178594983?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335817,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has announced that on September 25, 2026, the company spent HK$6.8 million to repurchase 4 million shares, at a repurchase price of HK$1.695 to HK$1.7 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670844474","title":"Peijia Medical Says B. Braun's Intracranial Drug-Coated Balloon Gets China Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2670844474","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670844474?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:58","pubTimestamp":1790333891,"startTime":"0","endTime":"0","summary":"Peijia Medical  said B. Braun Medical 's SeQuent Please CIS paclitaxel drug-coated intracranial balloon dilatation catheter has received approval from China's National Medical Products Administration.The device is designed to treat narrowed intracranial blood vessels using a paclitaxel drug-coated balloon, without leaving an implant in the vessel, according to a Friday filing on Hong Kong bourse.Peijia Medical unit Shanghai Achieva Medical Suzhou holds exclusive distribution rights for SeQuent Please CIS in mainland China.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1100","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180683376","title":"ANTENGENE-B (06996) Spends HK$504,900 to Repurchase 147,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1180683376","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180683376?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:09","pubTimestamp":1790330981,"startTime":"0","endTime":"0","summary":"ANTENGENE-B (06996) announced that on September 25, 2026, the company spent HK$504,900 to repurchase 147,000 shares.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1191","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132866662","title":"UBS Positive on InnoCare Pharma's Collaboration with Eli Lilly on Novel Target Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=1132866662","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132866662?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:16","pubTimestamp":1790327777,"startTime":"0","endTime":"0","summary":"UBS has issued a research report maintaining a \"Buy\" rating on InnoCare Pharma (09969) with a target price of HK$21.8.InnoCare Pharma has entered into a collaboration with Eli Lilly (LLY.US) to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688428","09969","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150900528","title":"Peijia Medical-B (09996): Shenpuchang™ SeQuent® Please CIS Paclitaxel Drug-Coated Intracranial Balloon Dilatation Catheter Registration Application Approved by National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=1150900528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150900528?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:08","pubTimestamp":1790327296,"startTime":"0","endTime":"0","summary":"Peijia Medical-B (09996) has announced that the registration application for Shenpuchang™ SeQuent® Please CIS paclitaxel drug-coated intracranial balloon dilatation catheter (\"SeQuent® Please CIS\" or...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","09996","BK1583","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670660449","title":"Peijia Medical - Shanghai Achieva Medical Suzhou Obtains Exclusive Distribution Rights for Sequent® Please CIS in Chinese Mainland","url":"https://stock-news.laohu8.com/highlight/detail?id=2670660449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670660449?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:01","pubTimestamp":1790326901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1B0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09996","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670449654","title":"Peijia Medical - Sequent® Please CIS Balloon Dilatation Catheter Receives Nmpa Registration Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2670449654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670449654?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:01","pubTimestamp":1790326901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1574","09996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133697705","title":"Hong Kong Stock Market Movers: CRO Sector Leads Gains as Citi Signals Positive Outlook for U.S. Licensing Policy Toward Chinese Drugmakers, Remains Bullish on Innovative Drugs and Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1133697705","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133697705?lang=en_us&edition=fundamental","pubTime":"2026-09-25 13:54","pubTimestamp":1790315655,"startTime":"0","endTime":"0","summary":"CRO-related stocks are among the top gainers, with GENSCRIPT BIO (01548) up 9.16% at HK$43.38, ASYMCHEM (06821) up 3.81% at HK$155.4, WUXI APPTEC (02359) up 2.44% at HK$210, WUXI BIO (02269) up 2.31%...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LU1267930227.SGD","HK0000306685.HKD","IYF","LU0348766576.USD","LU0359202008.SGD","LU0417516738.SGD","01548","LU0052750758.USD","LU1046422090.SGD","LU0417516902.SGD","LU2125154778.USD","LU2236285917.USD","LU2360032135.SGD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0072461881.USD","LU0326950275.SGD","BK4534","LU0106831901.USD","XBI","LU0348825331.USD","BK1610","BK4588","IBBJ","02269","LU1668664300.SGD","LU0039217434.USD","LU0162691827.USD","LU0314106906.USD","HK0000320223.HKD","LU1366192091.USD","BK4585","HK0000320264.USD","LU0098860793.USD","LU0516422440.USD","LU0029874061.USD","LU0516422952.EUR","MEDX","03347","LU1688375341.USD","LU0823426308.USD","LU0561508036.HKD","LU0708995583.HKD","BK1191","LU1162221912.USD","BK4566","LU0456827905.SGD","BK4504","LU2456880835.USD","LU0310800965.SGD","BK4581","LU3063872942.SGD","LU0980610538.SGD","KCAI","LU1506573853.SGD","LU0130517989.USD","LU0128522744.USD","159992","LU0572944931.SGD","SG9999002463.SGD","LU0170899867.USD","LU0307460666.USD","LU1242518931.SGD","LU1244550494.USD","BK1521","LU1144417596.USD","LU0348767384.USD","BK4559","LU0043850808.USD","VXUS","LU1794554557.SGD","BK1141","LU2039709279.SGD","BK4207","LU0203347892.USD","LU0348735423.USD","LU0516423091.SGD","LU2045819591.USD","BK1574","06821","LU0634319403.HKD","LU1720050803.USD","IBBQ","LU0203345920.USD","LU1201861249.SGD","LU2242644610.SGD","LU0320764243.SGD","GDOC","LU1242518857.USD","BK1583","LU0469268626.HKD","LU0819121731.USD","LU0130102774.USD","LU2125154935.USD","FTXO","LU0456846285.SGD","IE00B0JY6N72.USD","BK1161","02359","HBImain","LU0128525689.USD","LU0359201612.USD","LU0128526141.USD","C","LU1791807156.HKD","LU0516423174.USD","LU1074936037.SGD","BK1576","LU0181495838.USD","LU1244550221.USD","TFNS","LU0029874905.USD","LU0051755006.USD","LU0477156953.USD","HK0000306701.USD","LU0648001328.SGD","LU0540923850.HKD","06978","LU0516422366.SGD","LU0052756011.USD","LU0348827113.USD","LU0588546209.SGD","BK1589","LU0856984785.SGD","LU0327786744.USD","SG9999002562.SGD","LU1244550577.SGD","LU2125910500.SGD","SYNB","LU0979878070.USD","LU0320764599.SGD","159837","AGNG","LU0140636845.USD","LU0823426480.USD","LU1880383366.USD","KURE","LU2417539215.USD","LU0708995153.HKD","LU2462157665.USD","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161818471","title":"Kobayashi Pharmaceutical Says It Has Received Preliminary Take-Private Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=1161818471","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161818471?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:50","pubTimestamp":1790293815,"startTime":"0","endTime":"0","summary":"Following earlier reports, Kobayashi Pharmaceutical confirmed that it has received a preliminary, non-binding joint proposal from NSSK and an affiliate of CVC Capital Partners to take the company private.The company stated that no decision has been made at this time.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193610255","title":"Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention","url":"https://stock-news.laohu8.com/highlight/detail?id=1193610255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193610255?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:54","pubTimestamp":1790254489,"startTime":"0","endTime":"0","summary":"Huihe Medical's STAR Market IPO review status was changed to \"terminated\" on September 24, as the company and its sponsor withdrew the listing application, according to the relevant provisions of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","LNGR","LGHT","159891","IPOS","FRHC","BK1100","MEDX","BK4127","MDEV","HART","09996","BK1574","KCE","PTH","GDOC","BK1583","159883","IEIH","AGNG","REDS","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669986554","title":"CStone Pharma CEO Buys HK$2.7 Million of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669986554","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669986554?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:33","pubTimestamp":1790253200,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals  said CEO, President of R&D and executive director Jianxin Yang bought 496,000 shares in the open market for more than HK$2.7 million from Sept. 17 to 22, according to a Thursday Hong Kong bourse filing.Following the purchases, Yang's interest in CStone rose to about 5.31% of the company's issued share capital. He has bought a total of 14.21 million shares in the open market since becoming CEO in August 2022.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104658454","title":"Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1104658454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104658454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:16","pubTimestamp":1790252179,"startTime":"0","endTime":"0","summary":"Lifetech Scientific (01302) has announced that on September 24, 2026, the company received formal written notification from the National Medical Products Administration confirming that the SureCham...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1583","HART","LNGR","RSPH","IEIH","PTH","BK1100","BK1600","MDEV","BK1574","MEDX","GDOC","159883","AGNG","LGHT","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132416534","title":"Dizal Pharmaceutical Executives Including CFO Lu Hongbin Plan to Reduce Shareholdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1132416534","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132416534?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:01","pubTimestamp":1790251288,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical has released a new announcement stating that five senior executives, including Chief Financial Officer Lu Hongbin, Deputy General Manager Chen Suqin, QINGBEIZENG, HONCHUNGTSUI,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","09939","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169310143","title":"CStone Pharma-B (02616) Announces CEO and Executive Director Yang Jianxin's Purchase of 496,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1169310143","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169310143?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:36","pubTimestamp":1790246176,"startTime":"0","endTime":"0","summary":"According to an announcement from CStone Pharma-B (02616), the company was informed by Dr. Yang Jianxin that between September 17 and 22, 2026, he purchased a total of 496,000 shares in the open...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":199,"code":"91000000","status":"200"}]}}